Ex Parte WEINER et al - Page 11




                  Appeal No. 2001-0759                                                                                                                    
                  Application 08/809,186                                                                                                                  

                  applicability of the rejection in view of appellants' Declaration evidence.  We come to                                                 
                  this conclusion upon noting the examiner appears to have accepted the exhibits                                                          
                  attached to the Declaration of Dr. Weiner as evidence of the enablement of the claimed                                                  
                  invention to inhibiting the proliferation of T-cells and monocytes.   We find the examiner                                              
                  proffers no reasoning as to why the evidence presented, supporting the inhibition of                                                    
                  proliferation of T-cells and monocytes, would not also support the inhibition of                                                        
                  proliferation of B cells.                                                                                                               
                           Upon review of the evidence of lack of enablement provided by the examiner and                                                 
                  the argument and evidence of appellants, we find that a preponderance of the evidence                                                   
                  supports the position of enablement of claims having the scope of pending claims 14,                                                    
                  15, 17, 21, 24, and 33-36.   The rejection of  claims 14, 15, 17, 21, 24, and 33-36 for                                                 
                  lack of enablement is reversed.                                                                                                         
                                                                  CONCLUSION                                                                              
                           The rejection of claims 14, 15, 17, 21, 24, and 33-36.  under 35 U.S.C. § 112,                                                 
                  first paragraph for lack of enablement to make and use the invention within the scope of                                                
                  the claims is reversed.                                                                                                                 
                           No time period for taking any subsequent action in connection with this appeal                                                 
                  may be extended under 37 CFR § 1.136(a).                                                                                                
                                                                    REVERSED                                                                              


                                                                                                   )                                                      
                                                                           11                                                                             





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007